BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CODA Genomics, Inc. Announces Collaboration Expansion With Viventia Biotech Inc. (VBI.TO)


12/20/2006 4:22:05 PM

LAGUNA HILLS, Calif., Dec. 19 /PRNewswire/ -- CODA Genomics announced today an expansion of its collaboration with Viventia Biotech (Mississauga, Ontario). As part of the expanded relationship, CODA will apply its proprietary Translational Engineering(TM) protein expression solutions to various antibody projects within Viventia.

"We are pleased to continue an expanded relationship with Viventia. The growing level of interest and impact of protein Translational Engineering(TM) on the pipelines of pharmaceutical companies validates our unique protein expression solutions," said Alan Carter, Senior Vice President of Business Development. Dr. Robert J. Molinari, CEO of CODA added, "These relationships are an important part of CODA demonstrating the enormous value of its Translational Engineering technology to virtually any biologic drug discovery process."

CODA's proprietary protein translation technologies address protein expression, solubility and activity challenges in rational design steps at all stages of pharmaceutical development. This important, revolutionary utilization of synthetic biology is changing the competitive landscape of many businesses which rely on successful protein production.

Terms of the relationships were not disclosed.

About CODA Genomics, Inc.

CODA Genomics, Inc. is a protein Translation Engineering(TM) company focused on proprietary, patented approaches to express proteins across a variety of eukaryotic and prokaryotic cell lines. This unique technology enables synthetic biology success by solving problems related to protein expression, activity and solubility.

www.codagenomics.com

CODA Genomics, Inc.

CONTACT: Alan Carter of CODA Genomics, Inc., +1-949-305-5505,acarter@codagenomics.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES